Transfection of M13 single-stranded viral DNA bearing a 3,N 4 -ethenocytosine lesion into Escherichia coli cells pretreated with UV results in a significant elevation of mutagenesis at the lesion site compared to that observed in untreated cells. This response, termed UVM, for UV modulation of mutagenesis, is induced by a variety of DNA-damaging agents and is distinct from known cellular responses to DNA damage, including the SOS response. This report describes our observation, as a part of our investigation of the UVM phenomenon, that E. coli cells bearing a mutA or mutC allele display a UVM-constitutive phenotype. These mutator alleles were recently mapped (M. M. Slupska, C. Baikalov, R. Lloyd, and J. H. Miller, Proc. Natl. Acad. Sci. USA 93:4380-4385, 1996) to the glyV (mutA) and glyW (mutC) tRNA genes. Each mutant allele was shown to arise by an identical mutation in the anticodon sequence such that the mutant tRNAs could, in principle, mistranslate aspartate codons in mRNA as glycine at a low level. Because a UVM-constitutive phenotype resulting from a mutation in a tRNA gene was unexpected, we undertook a series of experiments designed to test whether the phenotype was indeed mediated by the expression of mutant glycine tRNAs. We placed either a wild-type or a mutant glyV gene under the control of a heterologous inducible promoter on a plasmid vector. E. coli cells expressing the mutant glyV gene displayed all three of the following phenotypes: (i) missense suppression of a test allele, (ii) a mutator phenotype measured by mutation to rifampin resistance, and (iii) a UVM-constitutive phenotype. These phenotypes were not associated with cells expressing the wild-type glyV gene or with cells in which the mutant allele was present but was not transcriptionally induced. These observations provide strong support for the idea that expression of mutant tRNA can confer a mutator phenotype, including the UVMconstitutive phenotype observed in mutA and mutC cells. However, our data imply that low-level mistranslation of the epsilon subunit of polymerase III probably does not account for the observed UVM-constitutive phenotype. Our results also indicate that mutA ⌬recA double mutants display a normal UVM phenotype, suggesting that the mutA effect is recA dependent. The observations reported here raise a number of intriguing questions and raise the possibility that the UVM response is mediated through transient alteration of the replication environment.
Chemical and physical mutagens can induce mutations through two distinct pathways. In the direct pathway, the DNA lesions inflicted by the mutagen are misreplicated. In the second pathway, DNA lesions inflicted by the mutagen transiently alter the cellular physiology such as to affect mutation-fixation at the cognate lesions, at noncognate (i.e., heterologous) lesions, and possibly at unmodified bases. The Escherichia coli SOS response is believed to be an example of the second, inducible mutagenesis pathway. In the SOS response, DNA damage blocks DNA replication and generates a signal that ultimately derepresses the approximately 20 genes that constitute the SOS regulon (11) . SOS genes encode mostly DNA repair, replication, and recombination functions, with the lexA and recA gene products providing, respectively, the repression and derepression functions. The RecA protein is believed to have multiple additional functions during the SOS response.
3,N 4 -Ethenocystine (εC) is an exocyclic DNA lesion induced by carcinogens such as vinyl chloride (2) and ethylcarbamate (15) . It appears that εC lesions may also be induced by end products of lipid peroxidation and may thus be part of the spontaneous DNA damage burden (6) . We have previously shown that εC is a highly mutagenic DNA lesion that has in vitro and in vivo template characteristics expected for a noninstructive lesion (26, 28) . However, mutagenesis at this lesion was recA independent, an anomaly that led us to investigate the mechanisms by which εC induces mutations. Further investigation showed that when M13 single-stranded DNA (ssDNA) bearing a site-specific εC lesion was transfected into E. coli preirradiated with UV, mutation fixation at the εC site was elevated significantly (23, 24) . This enhancement in mutagenesis proved not to require the recA, umuD, or umuC gene and was therefore independent of the SOS response (27) . This response, termed UVM (UV modulation of mutagenesis), was subsequently shown to be induced by all major classes of DNAdamaging agents (32, 33) and to be distinct from most known cellular responses to DNA damage (21, 27, 33) . As part of our initial characterization of UVM, we screened E. coli mutator strains defective for the mutH, mutL, mutS, mutM, and mutY genes and concluded that the UVM response did not require any of those genes (21) . However, mutA and mutC, two relatively uncharacterized mutator strains originally isolated by Miller and coworkers (16) , showed a UVM-constitutive phenotype in that mutagenesis at an εC lesion borne on transfected M13 ssDNA was high in uninduced, as well as in UVM-induced, cells (this work). Slupska et al. (30) recently showed that although mutA and mutC mapped, respectively, to loci at 95 and 42 min on the E. coli chromosome, both alleles appeared to encode identical copies of a glycine tRNA molecule each bearing the same base substitution in the anticodon loop. In mutA cells, one of the three identical glyV genes located in a tandem cluster at 95 min was mutated, whereas in mutC cells, the single glyW gene at 42 min was mutated. In each case, the mutation changed the 3Ј-CCG anticodon (which recognizes the glycine 5Ј-GGU and 5Ј-GGC codons) to a 3Ј-CUG anticodon that can, in principle, mistranslate the aspartate codons 5Ј-GAU and 5Ј-GAC as glycine. Thus, the mutant tRNA could act as a missense suppressor that mistranslates a normal wild-type codon. Slupska et al. (30) have hypothesized that the increased mutation frequency of the strain may be attributed to a transient mutator effect imposed by mistranslation of catalytically important aspartic acid residues of the DNA polymerase III (pol-III) holoenzyme ε subunit that normally functions to edit base insertion errors.
Because a UVM-constitutive phenotype resulting from mutations in tRNA genes was unexpected, we have sought to obtain definitive evidence that expression of a mutant glycine tRNA can cause the observed UVM phenotype. Our results provide strong support for the notion that a tRNA mutation can indeed have a mutator effect and indicate that the recA gene is required for mediation of the mutA-mutC-encoded phenotypes. These data also raise the possibility that the transient mutator phenotypes displayed in UVM-induced cells and in mutA or mutC cells result from distinct pathways that may converge at a common effector mechanism.
MATERIALS AND METHODS
Bacterial strains and plasmids. Table 1 lists the E. coli strains and plasmids used in this study.
Strain construction. Plasmid pHM11 was constructed by cloning a 122-bp-long chemically synthesized tRNA gene under the control of an inducible (P trc ) promoter in the pSE380 vector (4) as described below. The pSE380 vector DNA was linearized with NcoI, and the ends were filled in with T4 DNA polymerase in the presence of all four deoxynucleoside triphosphates. The DNA was cut with HindIII to obtain a large (4,118-bp) vector fragment bearing a promoter-proximal blunt end and a staggered HindIII-compatible end. Eight oligonucleotides constituting the synthetic tRNA gene (which also includes its own transcription termination sequence derived from the E. coli rrnC gene) were 5Ј phosphorylated with T4 polynucleotide kinase in the presence of ATP. The phosphorylated oligonucleotides (150 pmol of each oligonucleotide) were annealed at 80°C for 5 min in 100 mM NaCl in a volume of 75 l (22). The assembled sequence had a promoter-proximal blunt end, the other end being a HindIII-compatible staggered end (Fig. 1) . A fivefold molar excess of the assembled DNA fragment bearing the mutant tRNA gene was ligated into the vector in a volume of 100 l for 16 h at 16°C with 1 U of T4 DNA ligase (Gibco-BRL) in an ATP-containing buffer provided by the vendor. One microgram of the ligated DNA was transformed into E. coli FTP5378 cells (19) , and plasmid DNAs from 17 transformants selected on Luria-Bertani (LB) plates supplemented with ampicillin (Sigma) at 50 g/ml were analyzed for restriction fragment patterns predicted for the tRNA gene clone. DNA sequencing was performed on one plasmid (pHM11) as a final confirmation of the cloned sequence (data not shown). All of the enzymes used in the plasmid construction procedures described above were from New England Biolabs. Plasmid pHM22, a control plasmid containing a wild-type copy of the tRNA gene, was constructed exactly as described above, except that appropriate oligonucleotides specifying the wild-type version of the tRNA were substituted for the corresponding mutant oligonucleotides (see legend for Fig. 1) .
The E. coli ⌬recA mutA (HM105) and ⌬recA mutC (HM106) strains were constructed by P1 transduction (17) of the ⌬(srlR-recA)306::Tn10(Tet r ) locus from E. coli KH2R to the CC105mutA or CC105mutC strain. Transductants were found to display the expected UV sensitivity due to loss of recA function.
Background mutation frequency and missense suppression. Background mutation frequency was determined from the number of spontaneously arising rifampin-resistant mutants as previously described (17) . The ability of pHM11 to function as a missense suppressor was tested as follows. E. coli FTP5378 trpA cells harboring pHM11 (or appropriate control cells) were streaked on the following minimal plates: (i) minimal A medium (17), (ii) minimal A medium plus tryptophan at 20 g/ml, (iii) minimal A medium plus 1 mM isopropyl-␤-Dthiogalactopyranoside (IPTG; Sigma), and (iv) minimal A medium plus trypto-FIG. 1. DNA sequences of synthetic mutant and wild-type glyV tRNA genes in plasmids pHM11 and pHM22 showing major features and strategies used in their construction. The mutant tRNA gene in pHM11 was assembled by annealing eight 5Ј-phosphorylated deoxyribooligonucleotides (U1, U2, U3a, and U4 for the upper strand and L4, L3, L2a, and L1 for the lower strand). The sequence of the tRNA molecule extending from position 116 (5Ј end) through position 41 (3Ј end) is indicated in lowercase letters on the bottom strand. The sequence of the rrnC transcription terminator (base numbers 5 through 34) is indicated by uppercase italicization. The predicted Ϫ35, Ϫ10, and transcription start sites are indicated. The location of the base substitution mutation is indicated by the underlined base pair at position 82. The wild-type glyV tRNA gene was similarly assembled, except that the 19-mer 5Ј-GCGACCCCGACCTTGGCAA (U3b) and the 20-mer 3Ј-GCTGGAACCGTTCCAGCACG (L2b) were used to replace, respectively, the U3a and L2a oligonucleotides shown. As a result, the AT base pair at sequence position 82 in the mutant tRNA gene (pHM11) changes to GC in the wild-type version (pHM22). a The glyV55 mutation in FTP5378 codes for a tRNA species that can read GGA/G codons and permits the recovery of glyT mutants (5, 20, 31) . Note that wild-type E. coli has a total of four identical genes specifying the same tRNA species (three at the glyV locus and one at the glyW locus). phan at 20 g/ml and 1 mM IPTG. Plates were examined for growth after incubation at 37°C for 24 and 48 h.
Construction of M13 ssDNA bearing a site-specific C lesion and UVM assays. The construction of εC-containing vector ssDNA (εC-DNA) and that of control ssDNA have been described previously in detail (23, 27, 33) . LB medium (usually 100 ml) was inoculated with 0.01 volume of a fresh overnight saturated culture of the appropriate E. coli strain, and the cells were grown to exponential phase (about 10 8 cells/ml) at 37°C with vigorous aeration. The cultures were exposed to N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) at 0, 1, 5, or 10 g/ml for 10 min at 37°C (33) . The treated cells were pelleted at 3,600 ϫ g at 4°C and washed with an equal volume of ice-cold LB medium. The cells were resuspended in 1/10 of the original culture volume of ice-cold transformation and storage solution (10% polyethylene glycol 3350, 5% dimethyl sulfoxide, and 20 mM MgCl 2 in LB medium) and then incubated at 4°C for 40 min (23) . To induce the expression of the tRNA gene, all of the above steps (starting from the preparation of fresh overnight cultures) were carried out in the presence of 1 mM IPTG. One-milliliter aliquots of competent cells prepared as described above were transfected with 50 ng of εC-DNA or control ssDNA as previously described (23) . Effect of the lesion on survival was determined by plating for infectious centers. Pooled progeny phage DNA from each transfection was prepared either as previously described (23, 25) or by use of Qiaprep Spin M13 kits from Qiagen in accordance with the instructions provided by the vendor. Mutation fixation at the lesion site was analyzed by a quantitative multiplex DNA sequence analysis described previously (23, 25) and summarized in Fig. 2 .
RESULTS
Experimental system. The UVM response is detected as increased mutagenesis at the site of an εC lesion borne on an M13 ssDNA vector. As summarized in Fig. 2 , the system consists of (i) pretreatment of cells in the exponential growth phase with a UVM-inducing agent, (ii) transfection of ssDNA bearing the lesion, (iii) plating of transfected cells for infectious centers to monitor survival effects of the lesion, (iv) preparation of pooled progeny phage DNA from each transfection, and (v) multiplex sequence analysis of the pooled progeny DNA.
mutA and mutC cells have a UVM-constitutive phenotype. Figure 3A shows an example of a normal UVM response as observed in E. coli CC105 cells. When untreated cells are transfected with εC-DNA (Fig. 3A , MNNG at 0 g/ml) mutagenesis at the εC lesion is relatively low, as indicated by light 21-and 22-mer bands representing C3T and C3A mutations, respectively. Pretreatment of cells with MNNG dramatically enhances the intensity of the 21-and 22-mer bands such that approximately 50% of the progeny are mutant at an MNNG concentration of 5 g/ml (see Table 2 , experiment A, for a quantitative summary). Figure 3B and Table 2 , experiment B, show that mutation fixation is very high in untreated CC105mutA cells (Fig. 3B , lane 0 g/ml). Pretreatment of cells brings about relatively small changes in mutation frequency and specificity. A similar result is obtained with CC105mutC cells (Fig. 3C and Table 2 , experiment C), except that there is a further enhancement of mutagenesis in response to pretreatment with MNNG at 5 or 10 g/ml.
Construction and functional characterization of a plasmid vector expressing a mutant glyV tRNA gene. To test whether the observed UVM-constitutive phenotype of mutA cells is attributable to the expression of a mutant glyV tRNA, we constructed pHM11, a pSE380-derived plasmid in which a synthetic mutant glyV tRNA gene (Fig. 1 shows the DNA sequence) is placed under the control of the IPTG-inducible P trc promoter (4). Plasmid pHM22 is an identical construct, except that a wild-type glyV sequence has been inserted in place of the mutant tRNA gene. To test whether expression of the mutant tRNA is capable of acting as a missense suppressor tRNA, we transformed E. coli FTP5378 trpA(GAU234) with plasmid pHM11 or pHM22. FTP5378 is a missense suppressor test strain that is auxotrophic for tryptophan because of a glycine-to-aspartate change (resulting from a G ⅐ C3A ⅐ T base substitution) at position 234 of the trpA gene that specifies the ␣ subunit of tryptophan synthetase (19) . This strain can be reverted to tryptophan prototrophy by missense suppression such as to insert glycine or alanine at the mutated (Gly3Asp) codon. Figure 4 shows that FTP5378/pHM11 cells can grow in the absence of tryptophan, provided IPTG is included in the plate (cf. sectors b and e of plate C with those in plate A, the no-IPTG control). In contrast, FTP5378/pHM22 cells expressing the wild-type glyV tRNA do not grow in minimal medium with IPTG (Fig. 4 , plate C, sector d) or without IPTG (plate A, sector d). These observations suggest that expression of the mutant tRNA (but not that of wild-type tRNA) confers the FIG. 2. Summary of procedures used to detect the UVM response. Cells grown in the presence or absence of 1 mM IPTG to the exponential phase were exposed to MNNG at 0, 1, 5, or 10 g/ml for 10 min at 37°C and processed to render them transfection competent as described in Materials and Methods. Competent cells (1 ml) were transfected with 50 ng of M13 ssDNA bearing a site-specific εC residue (see inset at top right for structure). M13 ssDNA survival was determined by plating a 0.1-or 0.2-ml aliquot of transfected cells for infectious centers (ic), and the remainder was used to grow progeny phage as previously described (23, 25) . Pooled progeny phage DNA was isolated and subjected to quantitative multiplex sequence analysis to determine the mutation frequency and specificity as described in detail elsewhere (23, 25) and summarized at the right, where the immediate DNA sequence context of the lesion is shown (XϭεC). A 5Ј 32 P-end-labeled 19-mer primer (0.1 pmol) is annealed to pooled progeny phage DNA (0.2 pmol) and elongated in the presence of dGTP and dCTP (each at 1 M) and ddTTP (10 M) by T7 DNA polymerase devoid of 3Ј35Ј exonuclease activity (Sequenase 2.0; U.S. Biochemicals). The absence of dATP and the replacement of dTTP with ddTTP result in the production of limit elongation products whose length reflects the sequence of the template, as shown at the bottom. Thus, the 24-mer band derives from the wild-type (WT) fraction while the 21-mer, 22-mer, and 23-mer bands derive, respectively, from C3T, C3A, and Ϫ1-nucleotide (nt) mutant fractions. The elongation products are separated by high-resolution denaturing gel electrophoresis, and the autoradiographic signal in the bands is quantitated by computing densitometry as previously described (23, 25) . Mutation frequency is deduced as the ratio of combined signal in the mutant bands to that in all four bands as previously described (21 Table 3 , experiments B and C, shows that background mutagenesis, measured as the frequency of rifampin-resistant colonies, increases (as expected for mutator cells) for mutA and mutC cells compared with that of the wild-type parent (Table  3 , experiment A). Table 3 , experiment D, shows that expression of mutant glycine tRNA, but not that of wild-type glycine tRNA, elevates background mutagenesis significantly. Elevated mutagenesis in KH2/pHM11 cells (no IPTG) is probably due to basal expression of the tRNA gene on a multicopy vector plasmid (the estimated copy number per cell is 30 [1] ) under the experimental conditions used.
Expression of a mutant glycine tRNA gene confers a UVMconstitutive phenotype. Figure 5B and Table 2 , experiment I, show very high mutagenesis in IPTG-induced, untreated E. coli KH2/pHM11 cells (Fig. 5B , lane marked 0 g/ml), in contrast to the normal UVM response observed in IPTG-induced E. coli KH2/pHM22 cells (Fig. 5A and Table 2 , experiment H). The UVM-constitutive phenotype of KH2/pHM11 cells required IPTG (cf. data in Table 2 , experiments F and I), showing that expression of the mutant tRNA was necessary for the phenotype. Pretreatment of cells with MNNG also elevates the survival (number of infectious centers per microgram) of transfected DNA (e.g., Table 2 , experiments B and J), as noted previously (33). However, this stimulation (termed UVM reactivation) may represent a poorly understood effect on phage replication (see reference 32 for a discussion).
The UVM-constitutive phenotype conferred by mutant glycine tRNA expression, or by the mutA or mutC mutation, requires a functional recA gene but not a functional umuD or umuC gene. Figure 5D and Table 2 , experiment P, show that UVM induction is normal in IPTG-induced E. coli KH2R/ pHM11 cells, as evidenced by low mutagenesis at εC in untreated cells and a strong induction of mutations in cells pretreated with MNNG at 5 or 10 g/ml. Because E. coli KH2R is a ⌬recA derivative of KH2, these results imply that the UVMconstitutive phenotype of cells expressing the mutant glycine tRNA is recA dependent. Figure 5E and Table 2 , experiment R, show that the UVM-constitutive phenotype of mutA cells is not observed in ⌬recA mutA double-mutant cells, as evidenced by low mutagenesis in untreated cells (cf. these data and those in Fig. 5B and Table 2 , experiment I) and strong induction in pretreated cells. Figure 5F and Table 2 , experiment S, show essentially similar results for the ⌬recA mutC double mutant.
Because SOS induction requires the recA gene, it was interesting to investigate if umuD and umuC, two genes that are believed to play an essential role in SOS mutagenesis, are also required for the UVM-constitutive phenotype displayed by mutA or mutC cells. An analysis of E. coli SR100 ⌬umuD or -C cells harboring pHM11 showed a UVM-constitutive phenotype when mutant tRNA gene expression was induced by IPTG ( Table 2 , experiment Q), showing that the mutant tRNA-mediated phenotype did not require the umuD and umuC genes.
The data in Table 3 , experiment E, show the recA dependence of the mutator phenotype conferred by the expression of mutant glycine tRNA measured as spontaneous mutation to rifampin resistance. Thus, the pHM11 plasmid in the presence of IPTG fails to elevate mutagenesis in ⌬recA cells compared to the strong effect observed in recA ϩ cells (cf. Table 3 , experiments D and E). The data in Table 3 , experiment F, show that pHM11 (plus IPTG) does elevate mutation to rifampin resistance in ⌬umuDC cells, showing that the umuD and umuC genes are not required for the mutator phenotype. Finally, the data in Table 3 , experiments G and H, show that in a ⌬recA background, neither the mutA nor the mutC allele confers a mutator phenotype.
DISCUSSION
In this investigation, we sought definitive evidence that the UVM-constitutive phenotype we observed in mutA and mutC cells was linked to the expression of a mutant glycine tRNA gene. To that end, we constructed plasmid clones of the wildtype (glyV) and mutant (mutA) versions of the glycine tRNA gene such as to place the tRNA gene expression under the control of an IPTG-inducible promoter. The results described here satisfactorily link three phenotypes to the expression of the mutant tRNA gene: (i) missense suppression of a bona fide E. coli tester strain bearing a Gly3Asp mutation, (ii) a mutator phenotype measured as spontaneously arising rifampinresistant mutants, and (iii) a UVM-constitutive phenotype. Therefore, the data presented here provide strong support for the unexpected finding by Slupska et al. (30) that expression of a mutant tRNA can confer a mutator phenotype. However, as discussed below, these data do not support the hypothesis that low-level mistranslation of a subunit of pol-III can account for the mutator phenotypes.
The E. coli pol-III holoenzyme is an asymmetric dimeric complex consisting of 18 polypeptides built around two pol-III core assemblies. Each pol-III core is a stable complex of three polypeptides: the ␣ subunit is the actual DNA polymerase, and the ε subunit is the editing 3Ј35Ј exonuclease, whereas the function of the third subunit, , remains unknown (13) . The dimeric arrangement appears to reflect the functional requirements for coordinated replication of the leading and lagging strands. Point mutations in the ε subunit that abolish the editing 3Ј35Ј exonuclease activity confer very strong mutator phenotypes (7, 9) . Because deletion of the gene encoding the ε subunit (dnaQ) makes cells very sick (29) and because the pol-III core is a very stable ␣ε heterotrimer, the ε subunit may have additional structural and functional roles in the pol-III holoenzyme complex. The assembly of the pol-III holoenzyme appears to begin with the binding of the ␥ complex to a primed template, followed by the recruitment of a ␤ clamp and the pol-III core (13) . The ␤ ring confers such remarkable processivity on the holoenzyme that the enzyme is believed to remain stably associated with the replication fork until replication is complete. Analysis of the active sites of the ε subunit has identified a number of amino acid residues (including three   FIG. 3 . Examples of multiplex analyses of mutation fixation at an εC residue on M13 ssDNA transfected into mutA or mutC cells. Panels: A, wild-type (CC105) cells; B, mutA (CC105mutA) cells; C, mutC (CC105mutC) cells. Untreated and treated cells were transfected with ssDNA bearing εC, and phage progeny was subjected to multiplex sequence analysis as described in Fig. 2 . Mutagenesis is low in uninduced wild-type cells (panel A, MNNG at 0 g/ml), as indicated by light mutant bands (21-mer, 22-mer, and 23-mer) in comparison with the wild-type (24-mer) band. There is a striking increase in mutagenesis in response to pretreatment with MNNG at 5 or 10 g/ml. Mutagenesis in uninduced mutA cells (panel B, MNNG at 0 g/ml) is very high and does not appear to significantly increase further in response to MNNG pretreatment. Mutagenesis in uninduced mutC cells (panel C, MNNG at 0 g/ml) is also much higher than that observed in wild-type cells; however, a further increase in mutagenesis in response to MNNG pretreatment can be seen in mutC cells. The values to the right of each panel are the lengths in nucleotides of the limit elongation products. Table 1 for more complete genotypes. pSE380 is a plasmid vector (control), pHM22 is a plasmid bearing a wild-type glyV gene, and pHM11 is a plasmid bearing the mutant glyV gene.
b Cells were exposed to the indicated concentrations of MNNG for 10 min at 37°C, and then the MNNG was removed as described in Materials and Methods. c Survival of transfected DNA is expressed as the number of infectious centers (ic) per microgram of transfected DNA. d Mutation frequency and specificity were determined as previously described (21) . The data are averaged from at least six multiplex sequence elongation assays conducted on pooled progeny phage DNA obtained in two or more separate transfections, except for the following control strains, for which the data are averaged from a single transfection and three elongation assays: CC105 (experiment A), CC105mutC (experiment C), KH2/pSE380 (experiment D), KH2/pSE380 (experiment G), KH2R/pSE380 (experiment J), and KH2R/pSE380 (experiment M). Standard deviations were rounded to the nearest integer.
aspartates) as playing potentially important roles in the editing activity of the enzyme (3, 8, 10) . Slupska et al. (30) have proposed that the mutator effect of mutA or mutC cells may be mediated through low-level mistranslation of the ε subunit of the pol-III complex. Because missense suppression efficiency is around 1%, a similar fraction of mutant proteins are expected to form during protein synthesis. Such a mistranslation can create a small number of dominant-negative mutant ε subunit protein molecules in each cell expressing the mutant glycine tRNA. Occasional recruitment of the mutant protein into a pol-III holoenzyme will create a mutator polymerase. Thus, the hypothesis proposes that the tRNA mutation confers a transient mutator phenotype in a small subset of cells; therefore, mutant cells will have a normal wild-type phenotype much of the time but will express a temporary mutator phenotype at time intervals determined by the probability of recruitment of a dominant-negative ε subunit into a pol-III holoenzyme.
Replication of M13 viral DNA proceeds through two stages (14, 18) . In the first stage, the viral (plus) ssDNA is converted to a double-stranded replicative form (RF) through the following steps: (i) initiation of replication at a unique site (origin for the minus strand) by the priming action of E. coli RNA polymerase (12) , (ii) elongation of the primer by pol-III, (iii) primer removal and gap filling by DNA polymerase I, and (iv) nick sealing by ligase, followed by negative supercoiling by DNA gyrase. Mutation fixation in transfected ssDNA is believed to occur during this stage and therefore depends exclusively on host replication machinery. In stage 2, RF3RF, as well as RF3ssDNA, replication occurs through a rolling-circle mechanism in which the phage-specified gp2 protein introduces a nick at a unique site in the plus strand to set off replication, with all other replication functions provided by the host.
Although more complex scenarios can be imagined, it is likely that the UVM-constitutive phenotype displayed by mutA or mutC cells is mediated by the same mechanism that is responsible for the mutator phenotype. If so, the characteristics of the UVM-constitutive phenotype observed in mutA or mutC cells and in pHM11-bearing cells (in the presence of IPTG) suggest that mutation fixation must be occurring in a majority of cells. This observation is incompatible with the hypothesis that low-level mistranslation of the ε mRNA gives rise to a transient mutator phenotype when an occasional pol-III complex is assembled from a rare but defective ε subunit. Because missense suppression efficiency is thought to be low (1 to 2%), one anticipates that this mechanism can only be operative in a very small fraction of transfected cells. Thus, this mechanism appears unlikely to account for the UVM-constitutive phenotype we have described here.
However, the involvement of the ε subunit remains an attractive possibility. To retain a role for the ε subunit in the observed phenotypes, one can propose that the critical events in mutA cells are upstream of the ε subunit such that the activity of the ε subunit in a majority of pol-III complexes is affected. It is possible that an alteration in the translational rate or accuracy in mutA or -C cells activates a pathway that ultimately suppresses the editing activity of the ε subunit. Note, however, that mechanisms that do not involve the ε subunit have not been eliminated; indeed, there is no formal proof that mistranslation by the mutant glycine tRNA is required for the observed mutator phenotypes. For example, the signal that induces the mutator response may be generated by an altered interaction between the mutant glycine tRNA and an aminoacyl-tRNA synthetase. Our observation that the mutA phenotype requires a functional recA gene raises a number of interesting issues. Because the RecA protein is known to play several distinct roles in the SOS pathway, the recA dependence may indicate that the mutator phenotype is manifested during translesion DNA synthesis at sites of spontaneous DNA damage. However, because the mutator phenotype does not depend on the umuD or umuC gene, the SOS mutagenesis pathway does not appear to be involved. The second interesting issue is that the UVM response does not require a functional recA gene, whereas the UVM-constitutive phenotype in mutA cells does. These observations suggest that the mutA pathway and the UVM pathway are distinct. However, the striking resemblance in the frequency and specificity of mutations in UVM-induced cells and uninduced mutA cells raises the possibility that the two pathways converge at a shared effector molecule regardless of whether the effector is the ε subunit. Thus, one would imagine that increased mistranslation in mutA cells generates a constitutive signal that acts in a recA-dependent manner to reduce the fidelity of DNA replication, whereas in the UVM pathway, treatment with DNA-damaging agents transiently activates the same mechanism in a manner that bypasses the requirement for recA. Despite these intriguing possibilities, whether the same proximate mechanisms underlie elevated mutagenesis in mutA cells and in UVM-induced wild-type cells is a question that remains to be addressed.
